These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 16495239)

  • 41. Activity of the spiropiperidyl rifamycin LM 427 on rifampicin resistant Mycobacterium tuberculosis.
    Ungheri D; Della Bruna C; Sanfilippo A
    G Ital Chemioter; 1984; 31(3):211-4. PubMed ID: 6100178
    [No Abstract]   [Full Text] [Related]  

  • 42. In-vitro activity of rifabutin against rifampicin-resistant Mycobacterium tuberculosis isolates with known rpoB mutations.
    Cavusoglu C; Karaca-Derici Y; Bilgic A
    Clin Microbiol Infect; 2004 Jul; 10(7):662-5. PubMed ID: 15214882
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Emergence of ciprofloxacin resistance in nosocomial methicillin-resistant Staphylococcus aureus isolates. Resistance during ciprofloxacin plus rifampin therapy for methicillin-resistant S aureus colonization.
    Peterson LR; Quick JN; Jensen B; Homann S; Johnson S; Tenquist J; Shanholtzer C; Petzel RA; Sinn L; Gerding DN
    Arch Intern Med; 1990 Oct; 150(10):2151-5. PubMed ID: 2222100
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro and in vivo evaluation of L/105, a new topical intestinal rifamycin.
    Venturini AP; Marchi E
    Chemioterapia; 1986 Aug; 5(4):257-62. PubMed ID: 3533285
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effects of rifampin and rifabutin on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive.
    Barditch-Crovo P; Trapnell CB; Ette E; Zacur HA; Coresh J; Rocco LE; Hendrix CW; Flexner C
    Clin Pharmacol Ther; 1999 Apr; 65(4):428-38. PubMed ID: 10223781
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rifampin and rifaximin resistance in clinical isolates of Clostridium difficile.
    O'Connor JR; Galang MA; Sambol SP; Hecht DW; Vedantam G; Gerding DN; Johnson S
    Antimicrob Agents Chemother; 2008 Aug; 52(8):2813-7. PubMed ID: 18559647
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [In vitro activities of benzoxazinorifamycin KRM-1648 against Mycobacterium tuberculosis].
    Sato K; Tomioka H; Saito H; Kawahara S; Hidaka T
    Kekkaku; 1996 Aug; 71(8):459-64. PubMed ID: 8831191
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Selection of mutant rifampin-resistant Staphylococcus aureus during the therapeutic use of this antibiotic in combinations. 3 cases].
    Dellamonica P; Bernard E; Etesse H; Brun Y
    Sem Hop; 1983 Dec; 59(44):3087-8. PubMed ID: 6320397
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Structure-activity relationship studies of new rifamycins containing l-amino acid esters as inhibitors of bacterial RNA polymerases.
    Czerwonka D; Domagalska J; Pyta K; Kubicka MM; Pecyna P; Gajecka M; Przybylski P
    Eur J Med Chem; 2016 Jun; 116():216-221. PubMed ID: 27061985
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Is there any rationale for treatment of Staphylococcus aureus infections with antimicrobials that are determined to be ineffective in vitro?
    Uekötter A; Peters G; Becker K
    Clin Microbiol Infect; 2011 Aug; 17(8):1142-7. PubMed ID: 21672081
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development of a Dual-Acting Antibacterial Agent (TNP-2092) for the Treatment of Persistent Bacterial Infections.
    Ma Z; Lynch AS
    J Med Chem; 2016 Jul; 59(14):6645-57. PubMed ID: 27336583
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Susceptibility of Staphylococcus aureus biofilms to vancomycin, gemtamicin and rifampin].
    Kotulová D; Slobodníková L
    Epidemiol Mikrobiol Imunol; 2010 Apr; 59(2):80-7. PubMed ID: 20586169
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Evaluation of the use of rifampin combinations in severe staphylococcal infections. Apropos of the selection of 7 resistant mutants].
    Dellamonica P; Mondain V; Bernard E; Brun Y; Etesse H; Barbarin A; Sicard D
    Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):559-62. PubMed ID: 6462746
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The prevalence of antiseptic resistance genes (qacA/B and smr) and antibiotic resistance in clinical Staphylococcus aureus strains].
    Nakipoğlu Y; Iğnak S; Gürler N; Gürler B
    Mikrobiyol Bul; 2012 Apr; 46(2):180-9. PubMed ID: 22639307
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Blocking Bacterial Naphthohydroquinone Oxidation and ADP-Ribosylation Improves Activity of Rifamycins against Mycobacterium abscessus.
    Ganapathy US; Lan T; Krastel P; Lindman M; Zimmerman MD; Ho H; Sarathy JP; Evans JC; Dartois V; Aldrich CC; Dick T
    Antimicrob Agents Chemother; 2021 Aug; 65(9):e0097821. PubMed ID: 34228543
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antibacterial activity of rifamycins for M. smegmatis with comparison of oxidation and binding to tear lipocalin.
    Staudinger T; Redl B; Glasgow BJ
    Biochim Biophys Acta; 2014 Apr; 1844(4):750-8. PubMed ID: 24530503
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vitro activity of rifamycins alone and in combination with other antibiotics against Chlamydia trachomatis.
    Jones RB; Ridgway GL; Boulding S; Hunley KL
    Rev Infect Dis; 1983; 5 Suppl 3():S556-61. PubMed ID: 6635445
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genetic analysis of Staphylococcus aureus RNA polymerase mutants.
    Morrow TO; Harmon SA
    J Bacteriol; 1979 Jan; 137(1):374-83. PubMed ID: 33150
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro studies of Chlamydia trachomatis susceptibility and resistance to rifampin and rifabutin.
    Treharne JD; Yearsley PJ; Ballard RC
    Antimicrob Agents Chemother; 1989 Aug; 33(8):1393-4. PubMed ID: 2552911
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacokinetically-based prediction of the effects of antibiotic combinations on resistant Staphylococcus aureus mutants: in vitro model studies with linezolid and rifampicin.
    Firsov AA; Golikova MV; Strukova EN; Portnoy YA; Dovzhenko SA; Kobrin MB; Zinner SH
    J Chemother; 2017 Aug; 29(4):220-226. PubMed ID: 27748167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.